In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Interest income: |
Interest income on loans | 220.6 | 197.2 | 176.4 | 147.5 | 122.2 | 104.8 | 90.6 | 87.3 |
Interest income on investments | 45.6 | 42.4 | 36.9 | 29.2 | 21.8 | 16.8 | 13.3 | 11.9 |
| 269.8 | 243.3 | 216.5 | 179.5 | 146.3 | 123.1 | 105.2 | 100.4 |
Interest expense: |
Interest on borrowings | 8.0 | 2.8 | 0.5 | 0.0 | | | | |
| 22.5 | 14.3 | 10.3 | 8.9 | 8.6 | 8.7 | 8.5 | 8.4 |
Net interest income | 247.3 | 229.0 | 206.2 | 170.7 | 137.7 | 114.4 | 96.7 | 92.0 |
Provision for loan losses | 11.5 | 10.1 | 6.6 | 17.4 | 11.4 | | 4.3 | -8.0 |
Net interest income after provision for loan losses | 235.8 | 219.0 | 199.6 | 153.3 | 126.3 | 107.1 | 92.4 | 100.0 |
Other non-interest income | 36.0 | 37.0 | 43.1 | 44.9 | 42.7 | 41.4 | 39.3 | 37.3 |
Total non-interest income | 36.0 | 37.0 | 43.1 | 44.9 | 42.7 | 41.4 | 39.3 | 37.3 |
Non-interest expenses | 146.4 | 148.8 | 151.2 | 150.0 | 136.1 | 120.3 | 103.8 | 86.5 |
Pre-tax income before non-recurring items | 126.5 | 108.1 | 92.4 | 49.3 | 34.3 | 29.5 | 29.0 | 51.7 |
Non-recurring items | 1.0 | 0.9 | 0.9 | 1.1 | 1.3 | 1.3 | 1.1 | 0.9 |
Pre-tax income | 125.4 | 107.1 | 91.5 | 48.2 | 32.9 | 28.2 | 27.9 | 50.8 |
Income taxes | 33.1 | 28.1 | 24.1 | 13.4 | 9.3 | 8.0 | 7.8 | 13.7 |
Tax rate | 26.4% | 26.3% | 26.4% | 27.9% | 28.3% | 28.4% | 28.1% | 26.9% |
Net income | 92.3 | 79.0 | 67.4 | 34.7 | 23.6 | 20.2 | 20.0 | 37.2 |
Net margin | 34.0% | 30.9% | 27.8% | 17.5% | 14.0% | 13.6% | 15.2% | 27.1% |
|
Basic EPS | $2.07 | $1.77 | $1.51 | $0.85 | $0.64 | $0.61 | $0.69 | $1.28 |
Diluted EPS | $2.06 | $1.77 | $1.51 | $0.85 | $0.64 | $0.61 | $0.68 | $1.27 |
|
Shares outstanding (basic) | 44.6 | 44.6 | 44.5 | 40.9 | 37.0 | 33.1 | 29.2 | 29.1 |
Shares outstanding (diluted) | 44.8 | 44.7 | 44.7 | 41.1 | 37.1 | 33.2 | 29.4 | 29.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |